CONNECT WITH US
Tech

Tech

Over 65 and dealing with joint or back pain? The Saatva Rx dished out ‘consistent relief’ for our tester’s bad back, and at $425 off, now is a good time to buy

Tom's Guide logo

Published on

Add as a preferred source on Google
Over 65 and dealing with joint or back pain? The Saatva Rx dished out ‘consistent relief’ for our tester’s bad back, and at $425 off, now is a good time to buy

Back and joint pain can make sleeping a nightmare. It's something our mattress review team knows well and, in some people, the problem can get worse with age. But one of our testers found that the Saatva Rx mattress, now $1,714 (down from $2,139) at Saatva, offers "consistent relief" for her chronic pain, enabling her sleep better at night again.

Choosing the best mattress for your sleep style and body type can help ease general aches and pains. But the Saatva Rx takes things a step further, utilizing a Therapeutic Support Core and targeted lumbar quilting to provide relief for those with chronic pain.

The RX doesn't come cheap, but you can save $425 on every size in this year's Saatva Black Friday sale which is now live. Here's a closer look at the Rx and why it's one of the best Black Friday mattress deals for people with back and joint pain.

Rx (twin): was $2139 now $1714
In this month's Saatva mattress sale you can save $425 on all sizes of the Rx with our semi-exclusive link, reducing a queen to $3,214 (was $3,639). This is the biggest price drop we've seen on the Rx in months, so we recommend shopping with us today. Unless you want a split king — you can save $525 on this largest size of this top-rated luxury mattress by heading straight to Saatva. You also get a 365-night trial, lifetime warranty, and free white glove delivery.

Our Saatva Rx Mattress review score: ★★★★½ User score : ★★★★★ (600+ reviews) View Deal


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.